Cancer Letters · 2018 · 19 citations · 31 references
MedicineCancer BiologyOncologyEpigeneticsMolecular OncologyTumor ProgressionCancer EpigeneticsCancer ProgressionEpigenetic Regulation In CancerKidney CancerMalignant NeoplasmsRenal Cell CarcinomaCancer Epigenetic NetworksEpigenetic Alterations In CarcinogenesisEpigenetic Drug ResistanceEpigenetic Gene SilencingEpigenetic SilencingMolecular Drug ResistanceNeoplastic ProgressionTherapeutic Epigenetics
31
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
Toshiyuki Miyashita, Stanisław Krajewski, Maryla Krajewska et al. · PubMed · 1994 · 2.2K citations
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Eri Oda, Rieko Ohki, Hideki Murasawa et al. · Science · 2000 · 2.1K citations
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Yardena Samuels-Lev, Daniel O’Connor, Daniele Bergamaschi et al. · Molecular Cell · 2001 · 664 citations · Full text